Reuters logo
Bayhill Therapeutics files for $86.25 mln IPO
January 9, 2008 / 11:32 AM / 10 years ago

Bayhill Therapeutics files for $86.25 mln IPO

Jan 9 (Reuters) - Drug company Bayhill Therapeutics Inc filed with U.S. regulators on Wednesday to raise up to $86.25 million in an initial public offering of common stock.

The Palo Alto, California-based company told the U.S. Securities and Exchange Commission in a preliminary prospectus that Pacific Growth Equities LLC, Lazard Capital Markets, Merriman Curhan Ford & Co and Punk, Ziegel & Co were underwriting the IPO.

The company intends to list its common stock on the Nasdaq under the symbol “BHTX.” (Reporting by Varsha Tickoo in Bangalore; Editing by Himani Sarkar)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below